No retraction, correction or concern found when last checked on Nov 2, 2026.
Phase I trial of elactocin
ES Newlands, GJS Rustin, MH Brampton
British Journal of Cancer · 1996
Cited by papers we hold 5
- Nuclear transport proteins: structure, function and disease relevance · 2023No notice
- Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway · 2022Not checked
- XPO1-dependent nuclear export as a target for cancer therapy · 2020No notice
- Nucleo-cytoplasmic transport as a therapeutic target of cancer · 2014No notice
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents · 2014No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.